Publicacións en colaboración con investigadores/as de NewYork–Presbyterian Hospital (1)

2021

  1. Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: Results from the phase III, placebo-controlled QUAZAR AML-001 trial

    Haematologica